- Filed
- Dec 15, 2021 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2021 · Dec 14, 2021 | 93.73M sh |
| Current Liabilities | Q2 2021 · Oct 31, 2021 | $35.56M |
| Current Liabilities | Q2 2021 · Apr 30, 2021 | $34.96M |
| Total Liabilities | Q2 2021 · Oct 31, 2021 | $35.56M |
| Total Liabilities | Q2 2021 · Apr 30, 2021 | $34.97M |
| Current Assets | Q2 2021 · Oct 31, 2021 | $60.02K |
| Current Assets | Q2 2021 · Apr 30, 2021 | $182.47K |
| Total Assets | Q2 2021 · Oct 31, 2021 | $2.01M |
| Total Assets | Q2 2021 · Apr 30, 2021 | $2.15M |
| Eps Diluted | Q2 2021 · Oct 31, 2021 | $0.00 |
| Eps Diluted | Q2 2021 · Oct 31, 2021 | −$0.01 |
| Eps Diluted | Q2 2021 · Oct 31, 2020 | −$0.01 |
| Eps Diluted | Q2 2021 · Oct 31, 2020 | −$0.03 |
| Operating Cash Flow | Q2 2021 · Oct 31, 2020 | −$543.97K |
| Cash And Equivalents | Q2 2021 · Oct 31, 2020 | $53.04K |
| Cash And Equivalents | Q2 2021 · Apr 30, 2020 | $347.89K |
| Stockholders Equity restated | Q2 2021 · Oct 31, 2020 | −$30.13M |
| Stockholders Equity | Q2 2021 · Jul 31, 2020 | −$28.84M |
| Stockholders Equity restated | Q2 2021 · Apr 30, 2020 | −$27.58M |
| Sga Expense | Q2 2021 · Oct 31, 2020 | $50.37K |
| Sga Expense | Q2 2021 · Oct 31, 2020 | $100.52K |
| Net Income | Q2 2021 · Oct 31, 2020 | −$1.2M |
| Net Income | Q2 2021 · Oct 31, 2020 | −$2.39M |
| Net Income | Q2 2021 · Jul 31, 2020 | −$1.18M |